Vanguard Personalized Indexing Management LLC Has $866,000 Stake in Revvity Inc. $RVTY

Vanguard Personalized Indexing Management LLC decreased its stake in Revvity Inc. (NYSE:RVTY) by 39.8% in the third quarter, Holdings Channel reports. The institutional investor owned 9,875 shares of the company’s stock after selling 6,535 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Revvity were worth $866,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. UniSuper Management Pty Ltd raised its holdings in Revvity by 30.9% in the 3rd quarter. UniSuper Management Pty Ltd now owns 26,869 shares of the company’s stock worth $2,355,000 after acquiring an additional 6,343 shares during the period. FWG Holdings LLC raised its stake in shares of Revvity by 2.8% in the third quarter. FWG Holdings LLC now owns 6,215 shares of the company’s stock valued at $592,000 after purchasing an additional 167 shares in the last quarter. Rakuten Investment Management Inc. acquired a new position in shares of Revvity in the 3rd quarter valued at $636,000. Sage Mountain Advisors LLC raised its position in Revvity by 16.3% in the third quarter. Sage Mountain Advisors LLC now owns 2,957 shares of the company’s stock worth $259,000 after purchasing an additional 414 shares in the last quarter. Finally, Allstate Corp acquired a new position in shares of Revvity in the 3rd quarter worth approximately $369,000. 86.65% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Revvity

Here are the key news stories impacting Revvity this week:

• Positive Sentiment: Q4 results beat expectations — adjusted EPS $1.70 (vs. consensus ~ $1.55) and revenue $772.1M, up 5.9% year-over-year, showing improving top- and bottom-line momentum. Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With Estimates
• Positive Sentiment: Company raised FY2026 guidance — EPS guidance of $5.35–$5.45 and ~ $3.0B revenue guidance that sit above Street estimates, signaling management confidence in diagnostics strength. Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter
• Positive Sentiment: Immediate market reaction was positive as investors pushed the stock higher on the beat + outlook, supported by analyst notes highlighting the upside. Revvity, Inc. (RVTY) Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Management call/transcripts and slide deck are available — useful for investors wanting detail on segment trends, margin drivers and cadence of growth. Revvity (RVTY) Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Valuation debate: recent share weakness has prompted DCF/analyst pieces arguing the stock may be attractive vs. intrinsic value, but opinions vary — this may support longer-term buyers more than short-term traders. Is Revvity (RVTY) Attractive After Recent Share Price Weakness And DCF Valuation Gap
• Negative Sentiment: Headwinds remain in academic research funding, which could pressure parts of the business even as diagnostics performs well — a risk to sustaining growth across all segments. Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter

Analyst Ratings Changes

RVTY has been the subject of a number of recent analyst reports. Robert W. Baird increased their target price on shares of Revvity from $122.00 to $123.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 28th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $105.00 target price on shares of Revvity in a research note on Monday. Guggenheim began coverage on Revvity in a research report on Wednesday, October 15th. They issued a “neutral” rating on the stock. Bank of America cut Revvity from a “buy” rating to a “neutral” rating and set a $110.00 price objective on the stock. in a report on Monday, December 15th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Revvity in a research note on Monday, December 29th. Five equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $110.55.

Revvity Price Performance

Revvity stock opened at $106.98 on Tuesday. The company has a market capitalization of $12.13 billion, a price-to-earnings ratio of 53.76, a PEG ratio of 3.32 and a beta of 1.06. The company has a current ratio of 1.75, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36. Revvity Inc. has a 12 month low of $81.36 and a 12 month high of $126.57. The stock’s 50 day moving average is $104.09 and its 200-day moving average is $95.52.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Monday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.15. Revvity had a return on equity of 7.52% and a net margin of 8.44%.The business had revenue of $772.06 million during the quarter, compared to the consensus estimate of $759.81 million. During the same period in the previous year, the company posted $1.42 EPS. The firm’s quarterly revenue was up 5.9% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. Equities research analysts expect that Revvity Inc. will post 4.94 EPS for the current year.

Revvity declared that its Board of Directors has initiated a share buyback program on Monday, October 27th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the company to buy up to 8.7% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s leadership believes its stock is undervalued.

Revvity Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 8th. Stockholders of record on Friday, April 17th will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Friday, April 17th. Revvity’s payout ratio is presently 14.07%.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.